KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 127 filers reported holding KYMERA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $23,588,236 | +18.7% | 796,093 | 0.0% | 0.76% | +25.6% |
| Q4 2022 | $19,870,481 | +14.7% | 796,093 | 0.0% | 0.60% | +18.2% |
| Q3 2022 | $17,331,000 | -31.2% | 796,093 | +53.3% | 0.51% | -45.6% |
| Q2 2021 | $25,192,000 | +548.3% | 519,416 | +419.4% | 0.94% | +447.1% |
| Q1 2021 | $3,886,000 | -37.3% | 100,000 | 0.0% | 0.17% | -48.3% |
| Q4 2020 | $6,200,000 | +91.9% | 100,000 | 0.0% | 0.33% | +44.8% |
| Q3 2020 | $3,231,000 | – | 100,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |